| Literature DB >> 28945243 |
Abigail Culshaw1, Kristin Ladell2, Stephanie Gras3,4, James E McLaren2, Kelly L Miners2, Carine Farenc3,4, Heleen van den Heuvel3, Emma Gostick2, Wanwisa Dejnirattisai1, Apirath Wangteeraprasert1, Thaneeya Duangchinda5, Pojchong Chotiyarnwong1, Wannee Limpitikul6, Sirijitt Vasanawathana7, Prida Malasit8, Tao Dong9, Jamie Rossjohn2,4, Juthathip Mongkolsapaya1,8, David A Price2,10, Gavin R Screaton1.
Abstract
Adaptive immune responses protect against infection with dengue virus (DENV), yet cross-reactivity with distinct serotypes can precipitate life-threatening clinical disease. We found that clonotypes expressing the T cell antigen receptor (TCR) β-chain variable region 11 (TRBV11-2) were 'preferentially' activated and mobilized within immunodominant human-leukocyte-antigen-(HLA)-A*11:01-restricted CD8+ T cell populations specific for variants of the nonstructural protein epitope NS3133 that characterize the serotypes DENV1, DENV3 and DENV4. In contrast, the NS3133-DENV2-specific repertoire was largely devoid of such TCRs. Structural analysis of a representative TRBV11-2+ TCR demonstrated that cross-serotype reactivity was governed by unique interplay between the variable antigenic determinant and germline-encoded residues in the second β-chain complementarity-determining region (CDR2β). Extensive mutagenesis studies of three distinct TRBV11-2+ TCRs further confirmed that antigen recognition was dependent on key contacts between the serotype-defined peptide and discrete residues in the CDR2β loop. Collectively, these data reveal an innate-like mode of epitope recognition with potential implications for the outcome of sequential exposure to heterologous DENVs.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28945243 DOI: 10.1038/ni.3850
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606